FR2518994B1 - 2-(4-(4,4-dialkyl-2,6-piperidinedion-1-yl) butyl)-1-pyperazinyl) pyridines et leur application pharmacologique - Google Patents
2-(4-(4,4-dialkyl-2,6-piperidinedion-1-yl) butyl)-1-pyperazinyl) pyridines et leur application pharmacologiqueInfo
- Publication number
- FR2518994B1 FR2518994B1 FR8221751A FR8221751A FR2518994B1 FR 2518994 B1 FR2518994 B1 FR 2518994B1 FR 8221751 A FR8221751 A FR 8221751A FR 8221751 A FR8221751 A FR 8221751A FR 2518994 B1 FR2518994 B1 FR 2518994B1
- Authority
- FR
- France
- Prior art keywords
- piperidinedion
- pyperazinyl
- pyridines
- dialkyl
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
- -1 BUTYL Chemical class 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/334,689 US4361565A (en) | 1981-12-28 | 1981-12-28 | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2518994A1 FR2518994A1 (fr) | 1983-07-01 |
| FR2518994B1 true FR2518994B1 (fr) | 1986-09-05 |
Family
ID=23308356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8221751A Expired FR2518994B1 (fr) | 1981-12-28 | 1982-12-24 | 2-(4-(4,4-dialkyl-2,6-piperidinedion-1-yl) butyl)-1-pyperazinyl) pyridines et leur application pharmacologique |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4361565A (en:Method) |
| JP (1) | JPS58118583A (en:Method) |
| KR (1) | KR880002011B1 (en:Method) |
| AT (1) | AT380880B (en:Method) |
| AU (1) | AU560667B2 (en:Method) |
| BE (1) | BE895505A (en:Method) |
| CA (1) | CA1237722A (en:Method) |
| CH (1) | CH653682A5 (en:Method) |
| CY (1) | CY1378A (en:Method) |
| DE (1) | DE3248138A1 (en:Method) |
| DK (1) | DK162284C (en:Method) |
| ES (1) | ES8402832A1 (en:Method) |
| FI (1) | FI70892C (en:Method) |
| FR (1) | FR2518994B1 (en:Method) |
| GB (1) | GB2114121B (en:Method) |
| GR (1) | GR77101B (en:Method) |
| HK (1) | HK5188A (en:Method) |
| HU (1) | HU190827B (en:Method) |
| IE (1) | IE54620B1 (en:Method) |
| IT (1) | IT1158040B (en:Method) |
| KE (1) | KE3714A (en:Method) |
| LU (1) | LU84562A1 (en:Method) |
| NL (1) | NL8204974A (en:Method) |
| PT (1) | PT76037B (en:Method) |
| SE (1) | SE449748B (en:Method) |
| SG (1) | SG29687G (en:Method) |
| ZA (1) | ZA828546B (en:Method) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT387221B (de) * | 1980-09-08 | 1988-12-27 | Bristol Myers Co | Verfahren zur herstellung des neuen |
| US4524206A (en) * | 1983-09-12 | 1985-06-18 | Mead Johnson & Company | 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives |
| AT387773B (de) * | 1983-09-12 | 1989-03-10 | Bristol Myers Co | Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten |
| US4619930A (en) * | 1985-01-16 | 1986-10-28 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
| US4677104A (en) * | 1985-05-06 | 1987-06-30 | Bristol-Myers Company | Antipsychotic fused-ring pyridinylpiperazine derivatives |
| CA1278792C (en) * | 1985-05-06 | 1991-01-08 | Joseph P. Yevich | Antipsychotic fused-ring pyridinylpiperazine derivatives |
| US4757073A (en) * | 1986-09-30 | 1988-07-12 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use |
| EP0348460A4 (en) * | 1987-11-12 | 1991-11-27 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| US4855430A (en) * | 1987-11-12 | 1989-08-08 | American Home Products Corporation | Polycyclicamine with psychotropic activity |
| US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
| US5116970A (en) * | 1988-02-18 | 1992-05-26 | New James S | Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones |
| US5001130A (en) * | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
| US5098904A (en) * | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
| EP0482696B1 (en) * | 1990-10-23 | 1996-01-10 | Akzo Nobel N.V. | 4-[4- or 6-(Trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams |
| HU9301856D0 (en) * | 1990-12-24 | 1993-09-28 | Merrell Dow Pharma | Application of glutarimide derivatives for treating depressive and maniacal diseases |
| SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| EP2159226B1 (de) * | 2007-03-29 | 2016-08-31 | Joint-stock Company "Obninsk Chemical Pharmaceutical Company" | Antihistamin- und antiallergienmittel sowie verfahren zu seiner herstellung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
| BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
| US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
| IL57569A0 (en) * | 1978-06-20 | 1979-10-31 | Synthelabo | Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them |
| US4305944A (en) * | 1980-09-08 | 1981-12-15 | Mead Johnson & Company | N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones |
-
1981
- 1981-12-28 US US06/334,689 patent/US4361565A/en not_active Expired - Fee Related
-
1982
- 1982-11-19 ZA ZA828546A patent/ZA828546B/xx unknown
- 1982-11-22 CA CA000416080A patent/CA1237722A/en not_active Expired
- 1982-12-02 AU AU91084/82A patent/AU560667B2/en not_active Ceased
- 1982-12-03 KR KR8205431A patent/KR880002011B1/ko not_active Expired
- 1982-12-08 GR GR70020A patent/GR77101B/el unknown
- 1982-12-22 IT IT49720/82A patent/IT1158040B/it active
- 1982-12-23 JP JP57225099A patent/JPS58118583A/ja active Granted
- 1982-12-23 CY CY137882A patent/CY1378A/xx unknown
- 1982-12-23 ES ES518511A patent/ES8402832A1/es not_active Expired
- 1982-12-23 FI FI824443A patent/FI70892C/fi not_active IP Right Cessation
- 1982-12-23 DK DK573282A patent/DK162284C/da active
- 1982-12-23 GB GB08236592A patent/GB2114121B/en not_active Expired
- 1982-12-23 IE IE3068/82A patent/IE54620B1/en not_active IP Right Cessation
- 1982-12-23 NL NL8204974A patent/NL8204974A/nl unknown
- 1982-12-23 AT AT0467682A patent/AT380880B/de not_active IP Right Cessation
- 1982-12-24 FR FR8221751A patent/FR2518994B1/fr not_active Expired
- 1982-12-27 SE SE8207426A patent/SE449748B/sv not_active IP Right Cessation
- 1982-12-27 HU HU824172A patent/HU190827B/hu not_active IP Right Cessation
- 1982-12-27 PT PT76037A patent/PT76037B/pt not_active IP Right Cessation
- 1982-12-27 DE DE19823248138 patent/DE3248138A1/de active Granted
- 1982-12-27 CH CH7565/82A patent/CH653682A5/de not_active IP Right Cessation
- 1982-12-28 BE BE0/209827A patent/BE895505A/fr not_active IP Right Cessation
- 1982-12-29 LU LU84562A patent/LU84562A1/fr unknown
-
1987
- 1987-03-27 SG SG296/87A patent/SG29687G/en unknown
- 1987-03-31 KE KE3714A patent/KE3714A/xx unknown
-
1988
- 1988-01-21 HK HK51/88A patent/HK5188A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2518993B1 (fr) | 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl))-1-piperazinyl) pyrimidines, leur preparation et leur application pharmacologique | |
| FR2518994B1 (fr) | 2-(4-(4,4-dialkyl-2,6-piperidinedion-1-yl) butyl)-1-pyperazinyl) pyridines et leur application pharmacologique | |
| NO850085L (no) | 4-(bicykliske heterocyklyl)-metyl og -hetero)-piperidiner | |
| FI865025A7 (fi) | 2-(3,5-dihalogeeni-4-aminobentsyyli) imidatsoliineja. | |
| FI854024A7 (fi) | Heterosykliset amidit. | |
| NO852404L (no) | Doerkonstruksjon. | |
| NO1994027I1 (no) | Omeprazol | |
| DE3571618D1 (de) | 2-(n-substituteguanidino)-4-hetero-arylthiazole antiulcer agents | |
| DK156479C (da) | 2-(2-fluor-4-halogen-5-substitueret-phenyl)-hydantoinderivater | |
| FI883282A7 (fi) | 2-(heterocyklylalkyl) imidatsopyridiner. | |
| SE7805011L (sv) | 4-aminometyl-1-(3,3,3-triarylpropyl)-4-arylpiperidin och derivat derav | |
| FI885424A0 (fi) | Diacylderivat av 4-(trialkylbensyl) -piperazinylfoereningar. | |
| FI860136A0 (fi) | Antipsykotiska cykliska imidderivat av 2-(4-butylpiperazin-1-yl)pyridiner. | |
| DK248685A (da) | Herbicide 2-(2-imidazolin-2-yl)-fluoralkoxy-, alkenyloxy- og alkynyloxypyridiner og -quinoliner | |
| DK142086D0 (da) | 4-(isoxazolyl)-thiazol-2-oxaminsyrederivater | |
| IT8025324A0 (it) | Piridine e piramidine anti-infiammatorie e immunoregolatrici. | |
| NL190991C (nl) | Vrijdragende schuifdeur. | |
| BE884581A (fr) | Derives de la 4-(naphtalenyloxy)-piperidine, leur preparation et leur utilisation | |
| IT8219162A0 (it) | Piridine antiinfiammatorie e immunoregolatrici. | |
| BR8200603A (pt) | Herbicidas de 1-oxido de piridina substituida composicoes herbicidas e processo de aplicacao das mesmas | |
| IT1164975B (it) | 1,2,3,6-tetraidropiridine 4-(2-(2-fenile sostitutivo)etenil), n-alchenil- o alchinil-sostituite | |
| IT1230056B (it) | Derivato di 4-(piperidin-1-il) piridina ad attivita' antifibroplastica. | |
| PL205740A1 (pl) | Sposob wytwarzania nowych 2-(2',2'-dwuchlorowcowinylo)-cyklobutanonow i 2-(2',2',2'-trojchlorowcoetylo)-cyklobutanonow | |
| DK128084D0 (da) | Doer | |
| BG32170A1 (en) | 2- (2- thienyl)- 3- phenyl- 4- imino- 5- cyano- 3, 4- dihydropymidin and method forits obtaining |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |